Buy Diallyltryptamine (DALT) Cas 60676-77-9
Buy Diallyltryptamine (DALT) Cas 60676-77-9
Diallyltryptamine (DALT), also known as N,N-diallyltryptamine, is a tryptamine derivative which has been identified as a designer drug.[2][3]
Use and effects
According to Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved), the dose of DALT is greater than 40 mg orally and its duration is unknown.[1] Its effects were not described.[1] Per Stephen Szara and colleagues in much earlier publications however, DALT and other extended N,N-dialkyltryptamines produce similar effects to dimethyltryptamine (DMT) but are longer-lasting, with durations of up to 3 hours.[1][4][5]
Interactions
Pharmacology
Pharmacodynamics
| Target | Affinity (Ki, nM) |
|---|---|
| 5-HT1A | 100 |
| 5-HT1B | >10,000 |
| 5-HT1D | 689 |
| 5-HT1E | 378 |
| 5-HT1F | ND |
| 5-HT2A | 701 |
| 5-HT2B | 61 |
| 5-HT2C | 385 |
| 5-HT3 | >10,000 |
| 5-HT4 | ND |
| 5-HT5A | >10,000 |
| 5-HT6 | 1,718 |
| 5-HT7 | >10,000 |
| α1A | 1,663 |
| α1B | 1,369 |
| α1D | >10,000 |
| α2A | 124 |
| α2B | 305 |
| α2C | 901 |
| β1–β3 | >10,000 |
| D1, D2 | >10,000 |
| D3 | 672 |
| D4, D5 | >10,000 |
| H1 | 127 |
| H2–H4 | >10,000 |
| M1–M5 | >10,000 |
| I1 | ND |
| σ1 | 101 (rat) |
| σ2 | 356 (rat) |
| TAAR1Tooltip Trace amine-associated receptor 1 | ND |
| MORTooltip μ-Opioid receptor, DORTooltip δ-Opioid receptor | >10,000 |
| KORTooltip κ-Opioid receptor | 2,477 |
| SERTTooltip Serotonin transporter | 150 (Ki) |
| NETTooltip Norepinephrine transporter | 1,121 (Ki) |
| DATTooltip Dopamine transporter | 1,406 (Ki) |
| Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs:[6][7][8][9] | |
The receptor interactions of DALT have been studied.[6][7][8][9] The drug produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[10]
Chemistry
DALT has been used as an intermediate in the preparation of radiolabeled diethyltryptamine (DET).[11]
Synthesis
The chemical synthesis of DALT has been described.[1]
Analogues
Analogues of DALT include 4-HO-DALT, 4-AcO-DALT, 5-MeO-DALT, methylallyltryptamine (MALT), propylallyltryptamine (PALT), and isopropylallyltryptamine (iPALT), among others.[1]
History
DALT was first described in the scientific literature by Stephen Szara and colleagues by 1962.[4][5]
Society and culture
Legal status
Canada
DALT is not an explicitly nor implicitly controlled substance in Canada as of 2025.[12]
United States
DALT is not an explicitly controlled substance in the United States.[13] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
Reviews
There are no reviews yet.